This inventor holds 1 USPTO granted patent. Top assignee: Chiron Viagene, Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Innovations of Nicholas J De Polo
Introduction
Nicholas J De Polo is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of biotechnology, particularly in the area of gene therapy. His work focuses on innovative methods for treating hemophilia through advanced retroviral delivery systems.
Latest Patents
Nicholas J De Polo holds a patent for the "Retroviral delivery of full length factor VIII." This patent encompasses retroviral vectors designed to direct the expression of full-length factor VIII in transduced host cells. The patent also details plasmids encoding these vectors and host cells that have been transformed, transfected, or transduced with them. Furthermore, it describes retroviral particles that incorporate these vectors, which can be amphotropic, ecotropic, polytropic, or xenotropic. The patent highlights methods for producing these retroviral particles in suitable packaging cells. Additionally, it discusses retroviral particles that are complement resistant and pharmaceutical compositions that utilize these particles for treating mammals, particularly humans, afflicted with hemophilia.
Career Highlights
Nicholas J De Polo has had a distinguished career, working with Chiron Viagene, Inc., where he has been instrumental in advancing gene therapy technologies. His innovative approaches have paved the way for new treatments in the medical field, particularly for patients suffering from hemophilia.
Collaborations
Throughout his career, Nicholas has collaborated with esteemed colleagues, including James G Respess and Stephen Chang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.
Conclusion
Nicholas J De Polo's contributions to the field of biotechnology, particularly through his patent on retroviral delivery systems, demonstrate his commitment to innovation and improving medical treatments. His work continues to impact the lives of those affected by hemophilia, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile